HealthEquity Dirección
Dirección controles de criterios 3/4
El CEO de HealthEquity es Jon Kessler , nombrado en Feb 2014, tiene una permanencia de 10.75 años. compensación anual total es $13.45M, compuesta por 5.2% salario y 94.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.35% de las acciones de la empresa, por valor de $31.87M. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 7.7 años, respectivamente.
Información clave
Jon Kessler
Chief Executive Officer (CEO)
US$13.4m
Compensación total
| Porcentaje del salario del CEO | 5.2% |
| Permanencia del CEO | 10.8yrs |
| Participación del CEO | 0.4% |
| Permanencia media de la dirección | 3yrs |
| Promedio de permanencia en la Junta Directiva | 7.7yrs |
Actualizaciones recientes de la dirección
Recent updates
HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 20
HealthEquity: High Marks For Recent Profit Growth
Nov 20We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | US$106m |
| Apr 30 2024 | n/a | n/a | US$80m |
| Jan 31 2024 | US$13m | US$700k | US$56m |
| Oct 31 2023 | n/a | n/a | US$29m |
| Jul 31 2023 | n/a | n/a | US$13m |
| Apr 30 2023 | n/a | n/a | -US$8m |
| Jan 31 2023 | US$13m | US$700k | -US$26m |
| Oct 31 2022 | n/a | n/a | -US$59m |
| Jul 31 2022 | n/a | n/a | -US$62m |
| Apr 30 2022 | n/a | n/a | -US$55m |
| Jan 31 2022 | US$10m | US$700k | -US$44m |
| Oct 31 2021 | n/a | n/a | -US$6m |
| Jul 31 2021 | n/a | n/a | US$723k |
| Apr 30 2021 | n/a | n/a | US$4m |
| Jan 31 2021 | US$9m | US$667k | US$9m |
| Oct 31 2020 | n/a | n/a | US$3m |
| Jul 31 2020 | n/a | n/a | -US$20m |
| Apr 30 2020 | n/a | n/a | -US$332k |
| Jan 31 2020 | US$5m | US$500k | US$40m |
| Oct 31 2019 | n/a | n/a | US$53m |
| Jul 31 2019 | n/a | n/a | US$90m |
| Apr 30 2019 | n/a | n/a | US$93m |
| Jan 31 2019 | US$5m | US$483k | US$74m |
| Oct 31 2018 | n/a | n/a | US$67m |
| Jul 31 2018 | n/a | n/a | US$61m |
| Apr 30 2018 | n/a | n/a | US$56m |
| Jan 31 2018 | US$4m | US$400k | US$47m |
Compensación vs. Mercado: La compensación total de Jon($USD13.45M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD7.74M).
Compensación vs. Ingresos: La compensación de Jon ha sido consistente con los resultados de la empresa en el último año.
CEO
Jon Kessler (56 yo)
10.8yrs
Permanencia
US$13,448,018
Compensación
Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 10.8yrs | US$13.45m | 0.35% $ 31.9m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 85.4m | |
| CFO & Executive VP | 1.2yrs | US$5.23m | 0.0086% $ 784.7k | |
| Executive VP & CTO | 2.7yrs | US$4.81m | 0.0033% $ 298.6k | |
| Executive VP | 8.2yrs | US$2.64m | 0.044% $ 4.0m | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Executive Vice President of Sales & Relationship Management | 3.3yrs | sin datos | sin datos | |
| Executive Vice President of Corporate Development & Strategy | 7.6yrs | sin datos | sin datos | |
| Executive VP & Chief Marketing Officer | 2.8yrs | sin datos | sin datos | |
| Executive VP & Chief People Officer | 1.6yrs | sin datos | sin datos | |
| Senior VP & Head of Product | 2yrs | sin datos | sin datos | |
| Executive VP & Chief Security Officer | no data | sin datos | sin datos |
3.0yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HQY se considera experimentado (3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 15.7yrs | US$13.45m | 0.35% $ 31.9m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 85.4m | |
| Independent Director | 8.2yrs | US$297.50k | 0.062% $ 5.7m | |
| Independent Non-Executive Chairman | 9.2yrs | US$362.50k | 0.065% $ 6.0m | |
| Independent Director | 2.2yrs | US$272.50k | 0.0050% $ 457.9k | |
| Independent Director | 10.3yrs | US$290.00k | 0.037% $ 3.3m | |
| Independent Director | 3.9yrs | US$280.00k | 0.035% $ 3.2m | |
| Independent Director | 7.3yrs | US$278.87k | 0.017% $ 1.6m | |
| Independent Director | 6.6yrs | US$275.00k | 0.012% $ 1.1m | |
| Independent Director | 2.5yrs | US$272.50k | 0.0096% $ 875.8k |
7.7yrs
Permanencia media
62.5yo
Promedio de edad
Junta con experiencia: La junta directiva de HQY se considera experimentada (7.7 años de antigüedad promedio).